Seattle Cancer Care Alliance (SCCA) brings together the leading research teams and cancer specialists of Fred Hutch, Seattle Childrens, and UW Medicine. One extraordinary group whose sole mission is the pursuit of better, longer, richer lives for our patients. SCCA's purpose is to provide state-of-the-art, patient and family centered care; support the conduct of cancer clinical research and education; enhance access to improved cancer interventions; and advance the standard of cancer care regionally and beyond.
This Clinical Technologist II position is a full time opening in the Cytogenetics Laboratory. Our focus is on cancer cytogenetics, primarily for patients with hematopoietic disorders. The hematopoietic stem cell transplant program at the SCCA brings in an interesting and challenging patient population. Our lab is growing rapidly and we have many opportunities to develop leading edge technologies.
Handles biological specimens and products; performs clinical assays and lab processes by following the Standard Operating Procedures
Operates analytical instruments, compiles and analyzes clinical data, verifies its accuracy, and reports results
Performs laboratory quality controls measurements
Prepares reagents and materials for clinical procedures
Enters patient and specimen information and results in the Laboratory Information Management System (LIMS)
Performs regular maintenance and troubleshooting on analytical instruments
Complete projects with minimal supervision
Perform specialized operational duties
Shares learned information Performs laboratory quality controls measurements
A Bachelors degree in a chemical, physical, biological or clinical laboratory science, or medical technology from an accredited institution
OR An associate degree in a laboratory science or medical laboratory technology from an accredited institution or equivalent education and training that includes 24 semester hours of medical laboratory technology courses or 24 semester hours of science courses that include six semester hours of chemistry, six semester hours of biology and twelve semester hours of chemistry, biology, or medical laboratory technology in any combination AND have laboratory training that includes completion of a clinical laboratory training program approved or accredited by an HHS-approved organization, or at least 3 months documented laboratory training is each specialty in which the individual performs high complexity testing.
Minimum of 2 years of clinical lab or research experience
Certification through ASCP in Molecular Biology and/or Cytogenetics
Proficiency with email, spreadsheets, and word processing
Manual computation skills
Ability to communicate verbally in person, on the phone, and in writing in a clear, concise and professional manner
Attention to detail
Ability to work in a high pressure, time-sensitive, and complex health care environment
Ability to identify and triage issues appropriately
Familiarity with medical terminology
Prior experience in a clinical cytogenetics laboratory
We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.